Indus Capital Partners, LLC Royalty Pharma PLC Transaction History
Indus Capital Partners, LLC
- $159 Million
- Q1 2024
Shares
2 transactions
Others Institutions Holding RPRX
# of Institutions
394Shares Held
275MCall Options Held
276KPut Options Held
236K-
Morgan Stanley New York, NY44.2MShares$1.14 Billion0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.7MShares$969 Million0.02% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$545 Million0.02% of portfolio
-
Baillie Gifford & CO16.7MShares$428 Million0.4% of portfolio
-
Viking Global Investors LP11.5MShares$295 Million1.33% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $11.2B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...